Large-scale testing (Phase 3)Study completedNCT00022516
What this trial is testing
Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer
Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 1,086